ARL Bio Pharma, Inc.

H-1B Sponsorship & Salary Data — Government-Verified

$73,001Avg. Salary
19Filings
13+Job Titles
December 2025Last Filing

According to TheRealSalaries.com analysis of official US Department of Labor filings (October 2024 - December 2025), ARL Bio Pharma, Inc. pays a median H-1B salary of $70,720 — 42% below the national median of $121,514. Based on 19 certified Labor Condition Applications.

Section 1

What does ARL Bio Pharma, Inc. pay?

ARL Bio Pharma, Inc.'s H-1B filings show an average salary of $73,001 based on 19 certified LCA applications. Salaries range from $51,418 to $113,300.

$73,001
Average
$70,720
Median
$51,418
Minimum
$113,300
Maximum

Recent H-1B Filings

Job TitleSalaryLocationDate
Data Review Chemist I $54,080 Oklahoma City, OK Dec 2025
Senior Data Review Chemist IV $79,040 Oklahoma City, OK Nov 2025
Data Review Chemist III $70,720 Oklahoma City, OK Aug 2025
R&D Scientist II $79,539 Oklahoma City, OK Aug 2025
Project Manager II $100,000 Oklahoma City, OK Jul 2025
Data Review Chemist III $74,880 Oklahoma City, OK Jul 2025
Data Review Chemist III-GMP $83,200 Oklahoma City, OK Jun 2025
R&D Project Coordinator $57,762 Oklahoma City, OK May 2025
Senior Data Review Scientist $79,040 Oklahoma, OK May 2025
Project Manager II $113,300 Oklahoma City, OK May 2025
Senior Protein Characterization Scientist $110,000 Oklahoma City, OK May 2025
Chemist II $64,459 Oklahoma City, OK May 2025
Chemist II $58,240 Oklahoma City, OK May 2025
Chemist I $56,014 Oklahoma City, OK Apr 2025
Chemist I $51,418 Oklahoma City, OK Apr 2025
Chemist I $55,162 Oklahoma City, OK Apr 2025
Chemist II $57,762 Oklahoma City, OK Mar 2025
Research Scientist III $62,400 Oklahoma City, OK Jan 2025
Project Manager 1 $80,000 Oklahoma City, OK Oct 2024
Section 2

States with ARL Bio Pharma, Inc. H-1B Filings

Section 3

All salaries above must meet the Department of Labor's wage floor — see how the H-1B prevailing wage levels work, or browse all sponsor companies.

Source: US Department of Labor LCA Disclosure Data. Last updated: Q1 FY2025.